Spravato (esketamine) Treatment at Summit Mental Health
Spravato® is an FDA-approved nasal spray used in conjunction with an oral antidepressant to treat:
Treatment-Resistant Depression (TRD) in adults who have not responded to at least two prior antidepressants
Major Depressive Disorder (MDD) with acute suicidal thoughts or behaviors in adults
At Summit Mental Health, we are proud to be a certified REMS (Risk Evaluation and Mitigation Strategy) treatment center, which means:
- Our team is specially trained to administer Spravato safely and effectively
- All treatments are provided under medical supervision in our office
- Patients are monitored for two hours after each dose to ensure safety and comfort
- Work with your insurance company to verify coverage and submit any necessary prior authorization requests
Spravato is given twice a week for the first month, then less frequently over time as part of a personalized treatment plan.
Contact us today to schedule a consultation. Relief may be closer than you think.